Orthocell’s stock soars following FDA 510(k) clearance of regenerative collagen medical device

BioWorld has reported on Orthocell’s rising share price, following the U.S. approval for our collagen medical device for dental guided bone and soft tissue regeneration applications. Read the article HERE.